These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9181569)

  • 1. Trick and treat: toward peptide mimic vaccines.
    Shikhman AR; Cunningham MW
    Nat Biotechnol; 1997 Jun; 15(6):512-3. PubMed ID: 9181569
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus.
    Agadjanyan M; Luo P; Westerink MA; Carey LA; Hutchins W; Steplewski Z; Weiner DB; Kieber-Emmons T
    Nat Biotechnol; 1997 Jun; 15(6):547-51. PubMed ID: 9181577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice by peptide vaccines].
    Takahashi A
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):147-56. PubMed ID: 9612708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on vaccine development in AIDS and cancer.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IAVI creates antibody scientist team.
    Birmingham K
    Nat Med; 2002 Aug; 8(8):768-9. PubMed ID: 12152016
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995.
    Berzofsky JA; Berkower IJ
    AIDS; 1995; 9 Suppl A():S143-57. PubMed ID: 8819581
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic structures recognized by T cells: towards the rational design of an AIDS vaccine.
    Cease KB; Berzofsky JA
    AIDS; 1988; 2 Suppl 1():S95-101. PubMed ID: 3147685
    [No Abstract]   [Full Text] [Related]  

  • 10. Steady but slow progress toward AIDS vaccine.
    Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nucleic acid vaccines for study in AIDS patients are approved. Vaccines of genetic molecules--humoral and cellular immune response].
    Hobom B
    Fortschr Med; 1995 Dec; 113(35-36):12. PubMed ID: 8582688
    [No Abstract]   [Full Text] [Related]  

  • 12. Disappointing data scuttle plans for large-scale AIDS vaccine trial.
    Cohen J
    Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines and immunology. Overview.
    Laurence J
    AIDS; 1988; 2 Suppl 1():S91-4. PubMed ID: 2852505
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS vaccine.
    Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen presentation and related immunological aspects of HIV-1 vaccines.
    Steinman RM; Germain RN
    AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
    [No Abstract]   [Full Text] [Related]  

  • 16. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology in AIDS in 1990.
    Sela M
    AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic peptides: a modern approach to vaccination.
    Sood A; Venugopalan P; Mysore N; Vyas SP
    Indian J Exp Biol; 1998 Sep; 36(9):849-61. PubMed ID: 9854423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes.
    Xu J; Ren L; Huang X; Qiu C; Liu Y; Liu Y; Shao Y
    AIDS; 2006 Nov; 20(18):2293-303. PubMed ID: 17117015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.